Summary:
Trial involving a biosimilar drug to test for psoriasis patients in a randomized double blind and active control trial for adults over 18 years old. The trial will last approximately one year.
Qualified Participants Must:
• Have psoriasis that is moderate to severe and are over 18 years old without being pregnant or planning pregnancy.
Qualified Participants May Receive:
Study drug and / or placebo in addition to office visits, physical exam and other non-invasive procedures. Participants will also get regular blood tests and will be compensated for time and travel.